Clinical Trial Update: Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing three anti-HIV regimens in treatment-naive patients has completed, assessing safety, effectiveness, and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED